Inventor · disambiguated record
Jerome F. Daanen
Also filed as: DAANEN JEROME · DAANEN JEROME F
34 granted patents·12 pending applications·199 citations·filing 1997–2017
96Inventor score
Top patents by PatentIndex Score
46 records- 0193US6809105B2Diazabicyclic central nervous system active agentsABBOTT LAB·Filed 2001·Granted Oct 26, 2004·53 cites·20 claims
- 0291US6833370B1Heterocycle substituted aminoazacycles useful as central nervous system agentsABBOTT LAB·Filed 2000·Granted Dec 21, 2004·40 cites·7 claims
- 0388US8084616B2TRPV1 antagonistsGOMTSYAN ARTHUR R·Filed 2008·Granted Dec 27, 2011·12 cites·13 claims
- 0488US7528134B2Acetamides and benzamides that are useful in treating sexual dysfunctionABBOTT LAB·Filed 2003·Granted May 5, 2009·26 cites·9 claims
- 0585US7998993B2TRPV1 antagonistsABBOTT LAB·Filed 2008·Granted Aug 16, 2011·8 cites·15 claims
- 0684US7022728B2Benzimidazoles that are useful in treating male sexual dysfunctionABBOTT LAB·Filed 2002·Granted Apr 4, 2006·14 cites·39 claims
- 0781US7998982B2Amide derivatives as TRPV1 antagonistsABBOTT LAB·Filed 2008·Granted Aug 16, 2011·4 cites·6 claims
- 0879US8119635B2Diazabicyclic central nervous system active agentsSCHRIMPF MICHAEL R·Filed 2009·Granted Feb 21, 2012·2 cites·9 claims
- 0979US6960589B2Benzimidazoles that are useful in treating sexual dysfunctionABBOTT LAB·Filed 2002·Granted Nov 1, 2005·14 cites·6 claims
- 1076US8232309B2Prodrugs of compounds that inhibit TRPV1 receptorGOMTSYAN ARTHUR R·Filed 2006·Granted Jul 31, 2012·2 cites·22 claims
- 1174US7319106B2Diazabicyclic central nervous system active agentsABBOTT LAB·Filed 2004·Granted Jan 15, 2008·5 cites·20 claims
- 1273US8604053B2TRPV1 antagonistsGOMTSYAN ARTHUR R·Filed 2009·Granted Dec 10, 2013·2 cites·32 claims
- 1369US8772499B2TRPV3 modulatorsABBVIE INC·Filed 2012·Granted Jul 8, 2014·1 cites·45 claims
- 1469US8772500B2TRPV3 modulatorsABBVIE INC·Filed 2012·Granted Jul 8, 2014·1 cites·33 claims
- 1568US7598236B2Diazabicyclic central nervous system active agentsABBOTT LAB·Filed 2007·Granted Oct 6, 2009·0 cites·19 claims
- 1667US7332504B2Heterocyclic substituted aminoazacycles useful as central nervous system agentsABBOTT LAB·Filed 2004·Granted Feb 19, 2008·2 cites·6 claims
- 1765US9783527B2Indazole ureas and method of useABBVIE INC·Filed 2015·Granted Oct 10, 2017·1 cites·41 claims
- 1863US7351828B2Benzimidazoles that are useful in treating sexual dysfunctionABBOTT LAB·Filed 2003·Granted Apr 1, 2008·0 cites·7 claims
- 1961US8030504B2Antagonists of the TRPV1 receptor and uses thereofABBOTT LAB·Filed 2007·Granted Oct 4, 2011·0 cites·9 claims
- 2060US2008090798A1Heterocyclic Substituted Aminoazacycles Useful as Central Nervous System AgentsABBOTT LAB·Filed 2007·Application pending·0 cites
- 2158US2012208820A1Diazabicyclic central nervous system active agentsSCHRIMPF MICHAEL R·Filed 2012·Application pending·0 cites
- 2256US7265115B2Diazabicyclic CNS active agentsABBOTT LAB·Filed 2003·Granted Sep 4, 2007·1 cites·14 claims
- 2355US2013165479A1Antagonists of the trpv1 receptor and uses thereofABBVIE INC·Filed 2012·Application pending·0 cites
- 2454US10266532B2Tricyclic modulators of TNF signalingABBVIE INC·Filed 2017·Granted Apr 23, 2019·0 cites·18 claims
- 2553US8350083B2Antagonists of the TRPV1 receptor and uses thereofABBVIE INC·Filed 2011·Granted Jan 8, 2013·0 cites·16 claims
- 2652US8796328B2TRPV1 antagonistsABBVIE INC·Filed 2013·Granted Aug 5, 2014·0 cites·25 claims
- 2752US7812019B2Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereofABBOTT LAB·Filed 2005·Granted Oct 12, 2010·0 cites·21 claims
- 2851US8609692B2TRPV1 antagonistsGOMTSYAN ARTHUR R·Filed 2009·Granted Dec 17, 2013·0 cites·24 claims
- 2948US8338603B2TRPV1 antagonistsGOMTSYAN ARTHUR R·Filed 2011·Granted Dec 25, 2012·0 cites·6 claims
- 3048US6133275A3-phenylpyrrolidine alpha-1 adrenergic compoundsABBOTT LAB·Filed 1998·Granted Oct 17, 2000·5 cites·15 claims
- 3148US2012277190A1Prodrugs of compounds that inhibit trpv1 receptorGOMTSYAN ARTHUR R·Filed 2012·Application pending·0 cites
- 3246US8859584B2TRPV1 antagonistsABBVIE INC·Filed 2012·Granted Oct 14, 2014·0 cites·20 claims
- 3346US2011288129A1Amide derivatives as trpv1 antagonistsVASUDEVAN ANIL·Filed 2011·Application pending·0 cites
- 3444US6001849AFuropyridine, thienopyridine pyrrolopyridine useful in controlling chemical synaptic transmissionABBOTT LAB·Filed 1997·Granted Dec 14, 1999·6 cites·14 claims
- 3542US9156788B2TRPV3 modulatorsABBVIE INC·Filed 2013·Granted Oct 13, 2015·0 cites·11 claims
- 3642US8969325B2TRPV1 antagonistsABBVIE INC·Filed 2012·Granted Mar 3, 2015·0 cites·31 claims
- 3741US2006189639A1Antagonists of the mGlu receptor and uses thereofSTEWART ANDREW O·Filed 2006·Application pending·0 cites
- 3841US2005176727A1Oximes and hydrazones that are useful in treating sexual dysfunctionFiled 2004·Application pending·0 cites
- 3940US8440691B2Tetrahydroquinolinyl compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereofGOMTSYAN ARTHUR·Filed 2010·Granted May 14, 2013·0 cites·18 claims
- 4040US2004029887A1Acetamides and benzamides that are useful in treating sexual dysfunctionFiled 2003·Application pending·0 cites
- 4140US2002169166A1Benzimidazoles that are useful in treating sexual dysfunctionFiled 2001·Application pending·0 cites
- 4240US2006009461A1Acetamides and benzamides that are useful in treating sexual dysfunctionBHATIA PRAMILA A·Filed 2005·Application pending·0 cites
- 4340US2004127504A1Benzimidazoles that are useful in treating sexual dysfunctionFiled 2003·Application pending·0 cites
- 4439US2003008878A1Benzimidazoles that are useful in treating sexual dysfunctionFiled 2001·Application pending·0 cites
- 4535US9682985B2(Indazol-4-yl) hexahydropyrrolopyrrolones and methods of useABBVIE INC·Filed 2016·Granted Jun 20, 2017·0 cites·19 claims
- 4631US8802711B2TRPV1 antagonistsGOMTSYAN ARTHUR·Filed 2012·Granted Aug 12, 2014·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Jerome F. Daanen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →